{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:37:50Z","timestamp":1792791470274,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12196-4","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T06:45:34Z","timestamp":1764830734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Role of biomarkers in predicting disease severity in acute dengue and SARs-CoV-2-Infected patients"],"prefix":"10.1186","volume":"26","author":[{"given":"Eakkawit","family":"Yamasmith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer D.","family":"Kinslow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin A.","family":"Cloherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James N.","family":"Moy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan L.","family":"Landay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupin","family":"Suputtamongkol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiwit","family":"Tantibhedhyangkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"12196_CR1","doi-asserted-by":"publisher","first-page":"805107","DOI":"10.3389\/fmed.2022.805107","volume":"9","author":"J Atallah","year":"2022","unstructured":"Atallah J, Mansour MK. Implications of using Host response-based molecular diagnostics on the management of bacterial and viral infections: a review. Front Med (Lausanne). 2022;9:805107. https:\/\/doi.org\/10.3389\/fmed.2022.805107.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"12196_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s00134-022-06956-y","volume":"49","author":"P P\u00f3voa","year":"2023","unstructured":"P\u00f3voa P, Coelho L, Dal-Pizzol F, Ferrer R, Huttner A, Conway Morris A, et al. How to use biomarkers of infection or sepsis at the bedside: guide to clinicians. Intensive Care Med. 2023;49(2):142\u201353. https:\/\/doi.org\/10.1007\/s00134-022-06956-y.","journal-title":"Intensive Care Med"},{"key":"12196_CR3","doi-asserted-by":"publisher","first-page":"16055","DOI":"10.1038\/nrdp.2016.55","volume":"2","author":"MG Guzman","year":"2016","unstructured":"Guzman MG, Gubler DJ, Izquierdo A, Martinez E, Halstead SB. Dengue infection. Nat Rev Dis Primers. 2016;2:16055. https:\/\/doi.org\/10.1038\/nrdp.2016.55.","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"12196_CR4","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1093\/cid\/ciz499","volume":"70","author":"FK Kan","year":"2020","unstructured":"Kan FK, Tan CC, Von Bahr Greenwood T, Khalid KE, Supramaniam P, Hed Myrberg I, et al. Dengue infection complicated by Hemophagocytic Lymphohistiocytosis: experiences from 180 patients with severe dengue. Clin Infect Dis. 2020;70(11):2247\u201355. https:\/\/doi.org\/10.1093\/cid\/ciz499.","journal-title":"Clin Infect Dis"},{"key":"12196_CR5","unstructured":"WHO. Guidelines approved by the guidelines review committee. Dengue: guidelines for diagnosis, treatment, prevention and control. In: World Health Organization. New. Geneva: World Health OrganizationCopyright\u00a9 2009; 2009."},{"key":"12196_CR6","doi-asserted-by":"publisher","first-page":"889196","DOI":"10.3389\/fimmu.2022.889196","volume":"13","author":"YK Yong","year":"2022","unstructured":"Yong YK, Wong WF, Vignesh R, Chattopadhyay I, Velu V, Tan HY, et al. Dengue infection - recent advances in disease pathogenesis in the era of COVID-19. Front Immunol. 2022;13:889196. https:\/\/doi.org\/10.3389\/fimmu.2022.889196.","journal-title":"Front Immunol"},{"issue":"8","key":"12196_CR7","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nri3014","volume":"11","author":"AL Rothman","year":"2011","unstructured":"Rothman AL. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol. 2011;11(8):532\u201343. https:\/\/doi.org\/10.1038\/nri3014.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"12196_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","volume":"19","author":"B Hu","year":"2021","unstructured":"Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141\u201354. https:\/\/doi.org\/10.1038\/s41579-020-00459-7.","journal-title":"Nat Rev Microbiol"},{"key":"12196_CR9","doi-asserted-by":"publisher","unstructured":"Ramasamy S, Subbian S. Critical determinants of cytokine storm and type I interferon response in COVID-19 pathogenesis. Clin Microbiol Rev. 2021;34(3). https:\/\/doi.org\/10.1128\/cmr.00299-20.","DOI":"10.1128\/cmr.00299-20"},{"key":"12196_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","volume":"53","author":"F Coperchini","year":"2020","unstructured":"Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: an overview of the involvement of the chemokine\/chemokine-receptor system. Cytokine Growth Factor Rev. 2020;53:25\u201332. https:\/\/doi.org\/10.1016\/j.cytogfr.2020.05.003.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"9","key":"12196_CR11","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/nrmicro2848","volume":"10","author":"NG Sandler","year":"2012","unstructured":"Sandler NG, Douek DC. Microbial translocation in hiv infection: causes, consequences and treatment opportunities. Nat Rev Microbiol. 2012;10(9):655\u201366. https:\/\/doi.org\/10.1038\/nrmicro2848.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"12196_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1128\/cmr.00050-12","volume":"26","author":"G Marchetti","year":"2013","unstructured":"Marchetti G, Tincati C, Silvestri G. Microbial translocation in the pathogenesis of hiv infection and aids. Clin Microbiol Rev. 2013;26(1):2\u201318. https:\/\/doi.org\/10.1128\/cmr.00050-12.","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"12196_CR13","doi-asserted-by":"publisher","first-page":"e0125123","DOI":"10.1128\/jvi.01251-23","volume":"97","author":"A Pliego Zamora","year":"2023","unstructured":"Pliego Zamora A, Kim J, Vajjhala PR, Thygesen SJ, Watterson D, Modhiran N, et al. Kinetics of severe dengue virus infection and development of gut pathology in mice. J Virol. 2023;97(11):e0125123. https:\/\/doi.org\/10.1128\/jvi.01251-23.","journal-title":"J Virol"},{"issue":"46","key":"12196_CR14","doi-asserted-by":"publisher","first-page":"7925","DOI":"10.3748\/wjg.v27.i46.7925","volume":"27","author":"K Roy","year":"2021","unstructured":"Roy K, Agarwal S, Banerjee R, Paul MK, Purbey PK. COVID-19 and gut immunomodulation. World J Gastroenterol. 2021;27(46):7925\u201342. https:\/\/doi.org\/10.3748\/wjg.v27.i46.7925.","journal-title":"World J Gastroenterol"},{"key":"12196_CR15","doi-asserted-by":"publisher","first-page":"1129190","DOI":"10.3389\/fimmu.2023.1129190","volume":"14","author":"G Eleftheriotis","year":"2023","unstructured":"Eleftheriotis G, Tsounis EP, Aggeletopoulou I, Dousdampanis P, Triantos C, Mouzaki A, et al. Alterations in gut immunological barrier in SARS-CoV-2 infection and their prognostic potential. Front Immunol. 2023;14:1129190. https:\/\/doi.org\/10.3389\/fimmu.2023.1129190.","journal-title":"Front Immunol"},{"issue":"4","key":"12196_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1615\/critrevimmunol.2014009988","volume":"34","author":"R Arakaki","year":"2014","unstructured":"Arakaki R, Yamada A, Kudo Y, Hayashi Y, Ishimaru N. Mechanism of activation-induced cell death of T cells and regulation of FasL expression. Crit Rev Immunol. 2014;34(4):301\u201314. https:\/\/doi.org\/10.1615\/critrevimmunol.2014009988.","journal-title":"Crit Rev Immunol"},{"issue":"8","key":"12196_CR17","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/s41418-022-00936-x","volume":"29","author":"S Andr\u00e9","year":"2022","unstructured":"Andr\u00e9 S, Picard M, Cezar R, Roux-Dalvai F, Alleaume-Butaux A, Soundaramourty C, et al. T cell apoptosis characterizes severe Covid-19 disease. Cell Death Differ. 2022;29(8):1486\u201399. https:\/\/doi.org\/10.1038\/s41418-022-00936-x.","journal-title":"Cell Death Differ"},{"key":"12196_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac724","author":"A Bhimraj","year":"2022","unstructured":"Bhimraj A, Morgan RL, Shumaker AH, Baden L, Cheng VCC, Edwards KM, et al. Infectious diseases society of America guidelines on the treatment and management of patients with COVID-19. Clin Infect Dis. 2022. https:\/\/doi.org\/10.1093\/cid\/ciac724.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"12196_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.5395\/rde.2016.41.1.74","volume":"41","author":"HY Kim","year":"2016","unstructured":"Kim HY. Statistical notes for clinical researchers: sample size calculation 1. comparison of two independent sample means. Restor Dent Endod. 2016;41(1):74\u201378. https:\/\/doi.org\/10.5395\/rde.2016.41.1.74.","journal-title":"Restor Dent Endod"},{"issue":"2","key":"12196_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/2229-3485.71856","volume":"1","author":"TV Sakpal","year":"2010","unstructured":"Sakpal TV. Sample size estimation in clinical trial. Perspect Clin Res. 2010;1(2):67\u201369.","journal-title":"Perspect Clin Res"},{"issue":"1","key":"12196_CR21","doi-asserted-by":"publisher","first-page":"19839","DOI":"10.1038\/s41598-020-76836-2","volume":"10","author":"S Dayarathna","year":"2020","unstructured":"Dayarathna S, Jeewandara C, Gomes L, Somathilaka G, Jayathilaka D, Vimalachandran V, et al. Similarities and differences between the \u2018cytokine storms\u2019 in acute dengue and COVID-19. Sci Rep. 2020;10(1):19839. https:\/\/doi.org\/10.1038\/s41598-020-76836-2.","journal-title":"Sci Rep"},{"key":"12196_CR22","doi-asserted-by":"publisher","unstructured":"Halstead SB. Dengue antibody-dependent enhancement: knowns and unknowns. Microbiol Spectr. 2014;2(6). https:\/\/doi.org\/10.1128\/microbiolspec.AID-0022-2014.","DOI":"10.1128\/microbiolspec.AID-0022-2014"},{"issue":"3","key":"12196_CR23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41423-022-00838-5","volume":"19","author":"SJ Choi","year":"2022","unstructured":"Choi SJ, Kim DU, Noh JY, Kim S, Park SH, Jeong HW, et al. T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the omicron variant. Cell Mol Immunol. 2022;19(3):447\u201348. https:\/\/doi.org\/10.1038\/s41423-022-00838-5.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"12196_CR24","doi-asserted-by":"publisher","first-page":"111995","DOI":"10.1016\/j.celrep.2023.111995","volume":"42","author":"S Meyer","year":"2023","unstructured":"Meyer S, Blaas I, Bollineni RC, Delic-Sarac M, Tran TT, Knetter C, et al. Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants. Cell Rep. 2023;42(1):111995. https:\/\/doi.org\/10.1016\/j.celrep.2023.111995.","journal-title":"Cell Rep"},{"issue":"6","key":"12196_CR25","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1080\/1744666x.2022.2074403","volume":"18","author":"R Ameratunga","year":"2022","unstructured":"Ameratunga R, Woon ST, Steele R, Lehnert K, Leung E, Brooks AES. Severe COVID-19 is a T cell immune dysregulatory disorder triggered by SARS-CoV-2. Expert Rev Clin Immunol. 2022;18(6):557\u201365. https:\/\/doi.org\/10.1080\/1744666x.2022.2074403.","journal-title":"Expert Rev Clin Immunol"},{"issue":"26","key":"12196_CR26","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.1016\/j.cell.2021.11.033","volume":"184","author":"D Wendisch","year":"2021","unstructured":"Wendisch D, Dietrich O, Mari T, von Stillfried S, Ibarra IL, Mittermaier M, et al. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell. 2021;184(26):6243\u201361.e27. https:\/\/doi.org\/10.1016\/j.cell.2021.11.033.","journal-title":"Cell"},{"issue":"1","key":"12196_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s41232-023-00272-8","volume":"43","author":"M Naito","year":"2023","unstructured":"Naito M, Kumanogoh A. Group 2 innate lymphoid cells and their surrounding environment. Inflamm Regen. 2023;43(1):21. https:\/\/doi.org\/10.1186\/s41232-023-00272-8.","journal-title":"Inflamm Regen"},{"issue":"3","key":"12196_CR28","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jaci.2014.11.001","volume":"135","author":"F Annunziato","year":"2015","unstructured":"Annunziato F, Romagnani C, Romagnani S. The 3 major types of innate and adaptive cell-mediated effector immunity. J Allergy Clin Immunol. 2015;135(3):626\u201335. https:\/\/doi.org\/10.1016\/j.jaci.2014.11.001.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"12196_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cyto.2015.05.019","volume":"75","author":"JJ McLeod","year":"2015","unstructured":"McLeod JJ, Baker B, Ryan JJ. Mast cell production and response to IL-4 and IL-13. Cytokine. 2015;75(1):57\u201361. https:\/\/doi.org\/10.1016\/j.cyto.2015.05.019.","journal-title":"Cytokine"},{"issue":"1","key":"12196_CR30","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s42003-022-03682-5","volume":"5","author":"CL Fonseka","year":"2022","unstructured":"Fonseka CL, Hardman CS, Woo J, Singh R, Nahler J, Yang J, et al. Dengue virus co-opts innate type 2 pathways to escape early control of viral replication. Commun Biol. 2022;5(1):735. https:\/\/doi.org\/10.1038\/s42003-022-03682-5.","journal-title":"Commun Biol"},{"key":"12196_CR31","doi-asserted-by":"publisher","first-page":"599805","DOI":"10.3389\/fimmu.2021.599805","volume":"12","author":"T Poonpanichakul","year":"2021","unstructured":"Poonpanichakul T, Chan-In W, Opasawatchai A, Loison F, Matangkasombut O, Charoensawan V, et al. Innate lymphoid cells activation and transcriptomic changes in response to human dengue infection. Front Immunol. 2021;12:599805. https:\/\/doi.org\/10.3389\/fimmu.2021.599805.","journal-title":"Front Immunol"},{"issue":"2","key":"12196_CR32","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1128\/jvi.01630-10","volume":"85","author":"MG Brown","year":"2011","unstructured":"Brown MG, Hermann LL, Issekutz AC, Marshall JS, Rowter D, Al-Afif A, et al. Dengue virus infection of mast cells triggers endothelial cell activation. J Virol. 2011;85(2):1145\u201350. https:\/\/doi.org\/10.1128\/jvi.01630-10.","journal-title":"J Virol"},{"issue":"6","key":"12196_CR33","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1189\/jlb.0805441","volume":"80","author":"MG Brown","year":"2006","unstructured":"Brown MG, King CA, Sherren C, Marshall JS, Anderson R. A dominant role for FcgammaRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release. J Leukoc Biol. 2006;80(6):1242\u201350. https:\/\/doi.org\/10.1189\/jlb.0805441.","journal-title":"J Leukoc Biol"},{"key":"12196_CR34","doi-asserted-by":"publisher","unstructured":"Syenina A, Jagaraj CJ, Aman SA, Sridharan A, St John AL. Dengue vascular leakage is augmented by mast cell degranulation mediated by immunoglobulin Fc\u03b3 receptors. Elife. 2015;4. https:\/\/doi.org\/10.7554\/eLife.05291.","DOI":"10.7554\/eLife.05291"},{"key":"12196_CR35","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1038\/mi.2008.46","volume":"1 Suppl 1","author":"F Heller","year":"2008","unstructured":"Heller F, Fromm A, Gitter AH, Mankertz J, Schulzke JD. Epithelial apoptosis is a prominent feature of the epithelial barrier disturbance in intestinal inflammation: effect of pro-inflammatory interleukin-13 on epithelial cell function. Mucosal Immunol. 2008;1 Suppl 1:S58\u201361. https:\/\/doi.org\/10.1038\/mi.2008.46.","journal-title":"Mucosal Immunol"},{"key":"12196_CR36","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.17179\/excli2020-3104","volume":"19","author":"KA Ullrich","year":"2020","unstructured":"Ullrich KA, Schulze LL, Paap EM, M\u00fcller TM, Neurath MF, Zundler S. Immunology of IL-12: an update on functional activities and implications for disease. Excli J. 2020;19:1563\u201389. https:\/\/doi.org\/10.17179\/excli2020-3104.","journal-title":"Excli J"},{"key":"12196_CR37","doi-asserted-by":"publisher","unstructured":"Chan AH, Schroder K. Inflammasome signaling and regulation of interleukin-1 family cytokines. J Exp Med. 2020;217(1). https:\/\/doi.org\/10.1084\/jem.20190314.","DOI":"10.1084\/jem.20190314"},{"key":"12196_CR38","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.csbj.2021.01.034","volume":"19","author":"BA Khalil","year":"2021","unstructured":"Khalil BA, Elemam NM, Maghazachi AA. Chemokines and chemokine receptors during COVID-19 infection. Comput Struct Biotechnol J. 2021;19:976\u201388. https:\/\/doi.org\/10.1016\/j.csbj.2021.01.034.","journal-title":"Comput Struct Biotechnol J"},{"key":"12196_CR39","doi-asserted-by":"publisher","first-page":"668507","DOI":"10.3389\/fimmu.2021.668507","volume":"12","author":"F Coperchini","year":"2021","unstructured":"Coperchini F, Chiovato L, Rotondi M. Interleukin-6, CXCL10 and infiltrating macrophages in COVID-19-Related cytokine storm: not one for all but all for one. Front Immunol. 2021;12:668507. https:\/\/doi.org\/10.3389\/fimmu.2021.668507.","journal-title":"Front Immunol"},{"key":"12196_CR40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cellimm.2015.11.003","volume":"300","author":"SS Okada","year":"2016","unstructured":"Okada SS, de Oliveira EM, de Ara\u00fajo TH, Rodrigues MR, Albuquerque RC, Mortara RA, et al. Myeloperoxidase in human peripheral blood lymphocytes: production and subcellular localization. Cell Immunol. 2016;300:18\u201325. https:\/\/doi.org\/10.1016\/j.cellimm.2015.11.003.","journal-title":"Cell Immunol"},{"issue":"1","key":"12196_CR41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s10020-021-00390-4","volume":"27","author":"NI Lor\u00e8","year":"2021","unstructured":"Lor\u00e8 NI, De Lorenzo R, Rancoita PMV, Cugnata F, Agresti A, Benedetti F, et al. CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study. Mol Med. 2021;27(1):129. https:\/\/doi.org\/10.1186\/s10020-021-00390-4.","journal-title":"Mol Med"},{"key":"12196_CR42","doi-asserted-by":"publisher","unstructured":"Mohandas S, Jagannathan P, Henrich TJ, Sherif ZA, Bime C, Quinlan E, et al. Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC). Elife. 2023;12. https:\/\/doi.org\/10.7554\/eLife.86014.","DOI":"10.7554\/eLife.86014"},{"issue":"10","key":"12196_CR43","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1097\/qad.0000000000000735","volume":"29","author":"CL Shive","year":"2015","unstructured":"Shive CL, Jiang W, Anthony DD, Lederman MM. Soluble CD14 is a nonspecific marker of monocyte activation. Aids. 2015;29(10):1263\u201365. https:\/\/doi.org\/10.1097\/qad.0000000000000735.","journal-title":"Aids"},{"issue":"7","key":"12196_CR44","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1128\/mcb.16.7.3490","volume":"16","author":"RR Schumann","year":"1996","unstructured":"Schumann RR, Kirschning CJ, Unbehaun A, Aberle HP, Knope HP, Lamping N, et al. The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF\/STAT\/3 and other cytokine-inducible nuclear proteins. Mol Cell Biol. 1996;16(7):3490\u2013503. https:\/\/doi.org\/10.1128\/mcb.16.7.3490.","journal-title":"Mol Cell Biol"},{"issue":"5","key":"12196_CR45","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/intimm\/dxae002","volume":"36","author":"Y Pat","year":"2024","unstructured":"Pat Y, Yazici D, D\u2019Avino P, Li M, Ardicli S, Ardicli O, et al. Recent advances in the epithelial barrier theory. Int Immunol. 2024;36(5):211\u201322. https:\/\/doi.org\/10.1093\/intimm\/dxae002.","journal-title":"Int Immunol"},{"key":"12196_CR46","doi-asserted-by":"publisher","first-page":"890817","DOI":"10.3389\/fcimb.2022.890817","volume":"12","author":"W Chancharoenthana","year":"2022","unstructured":"Chancharoenthana W, Kamolratanakul S, Ariyanon W, Thanachartwet V, Phumratanaprapin W, Wilairatana P, et al. Abnormal blood bacteriome, Gut Dysbiosis, and progression to severe dengue disease. Front Cell Infect Microbiol. 2022;12:890817. https:\/\/doi.org\/10.3389\/fcimb.2022.890817.","journal-title":"Front Cell Infect Microbiol"},{"key":"12196_CR47","doi-asserted-by":"publisher","unstructured":"Chancharoenthana W, Leelahavanichkul A, Ariyanon W, Vadcharavivad S, Phatcharophaswattanakul S, Kamolratanakul S, et al. Leaky gut syndrome is associated with endotoxemia and serum (1\u21923)-\u03b2-D-Glucan in severe dengue infection. Microorganisms. 2021;9(11). https:\/\/doi.org\/10.3390\/microorganisms9112390.","DOI":"10.3390\/microorganisms9112390"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12196-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12196-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12196-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:03:34Z","timestamp":1767841414000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12196-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12196"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12196-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"12 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Siriraj Hospital Institutional Review Board (certificate of approval 409\/2023) and Rush University Institutional Review Board, Office of Research Affairs# 21080502. The research was conducted in accordance with the Declaration of Helsinki. All participants were 18\u2009years of age or older. Informed consent to participate was obtained from all of the participants before the study. The research team restricted the participants\u2019 information and maintained confidentiality throughout the study period.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare the following financial interests\/personal relationships: MB, and GC are employees and shareholders of Abbott Laboratories. This work was funded by Abbott Laboratories. AL is a consultant for Abbott Laboratories. All other authors report no potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}